Li R, Hensley PJ, Gupta S, Al-Ahmadie H, Babjuk M, Black PC, Brausi M, Bree KK, Fernández MI, Guo CC, Horowitz A, Lamm DL, Lerner SP, Lotan Y, Mariappan P, McConkey D, Mertens LS, Mir C, Ross JS, O'Donnell M, Palou J, Pohar K, Steinberg G, Soloway M, Spiess PE, Svatek RS, Tan WS, Taoka R, Buckley R, Kamat AM. Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection.. EUROPEAN UROLOGY. 2024; 86(6)DOI:10.1016/j.eururo.2024.08.001. PMID:39183090. IF:(Q/D).

Trias I, Algaba F, de Torres I, Saco A, Marimon L, Peñuelas N, Diez-Ahijado L, Sisuashvili L, Darecka K, Morató A, Del Pino M, Ferrándiz-Pulido C, Ribal MJ, Ajami T, Corral JM, Gaya JM, Reig O, Ordi O, Ribera-Cortada I, García-Herrera A, Rakislova N. p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-Independent Penile Squamous Cell Carcinomas With Adverse Prognosis.. AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2024; 48(11)DOI:10.1097/PAS.0000000000002291. PMID:39040011. IF:(Q/D).

Pérez-Montero, H, Lozano, A, de Blas, R, Hernández, J, Mera, A, Guedea, F, Navarro-Martín, A. Patterns of failure after stereotactic body radiotherapy to non-spine bone metastases. Clinical & Translational Oncology. 2025; 27(8)DOI:10.1007/s12094-025-03878-1. PMID:40009131. IF:2.500(Q3/6D).

Maldonado, X, Boladeras, A, Gaya, JM, Muñoz, J, Planas, J, Sancho, G, Suárez, JF. Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel. Clinical & Translational Oncology. 2025; 27(7)DOI:10.1007/s12094-024-03833-6. PMID:39747804. IF:2.500(Q3/6D).

Najjari-Jamal, D, Rovirosa, A, Gimeno-Morales, M, Majercakova, K, Sánchez, M, Garcia, S, Guevara, D, Muñoz, T, de la Fuente, C, Micó, S, Stefanovic, M, Matute, R, Córdoba, S. Reirradiation Practice in Gynecological Cancer: Insights from a National Survey in Spain. Clinical & Translational Oncology. 2025; 27(6)DOI:10.1007/s12094-024-03804-x. PMID:39636497. IF:2.500(Q3/6D).

Sicre, JE, Ivars, M, Heinz, OH, Ludwig, PW, Verdun, JI, Torres, EB. Use of Postoperative Radiotherapy and Multiple Adjuvant Treatments After Surgical Removal of a Giant Retroauricular Keloid in a Pediatric Patient. PEDIATRIC DERMATOLOGY. 2025; 42(3)DOI:10.1111/pde.15787. PMID:39491479. IF:1.200(Q3/7D).

Crespo, SM, Montezuma, LC, Leon, X, Majercakova, K, Rojas, J, Calvet, G, Rabi, S, Piedra, MM, Juliá, JC, Sancho, G. influence the interval time between surgery and start of adjuvant radiotherapy for head and neck cancer prognosis. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).

Monetzuma, LC, Crespo, S, Leon, X, Majercakova, K, Rojas, J, Piedra, M, Calvet, G, Rabi, S, Julia, JC, Sancho, G. Prognostic capacity of pretreatment hematological parameters in patients with Head and neck cancer treated with chemo-bio Radiotherapy. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).

Perea, AD, Sala, NJ, Martínez, AR, Pagès, MB, García, JR, Marcos, CA, Molinero, VR, Fernandez, JPA, Franco, PG, Aguilar, NT, Bargalló, HV, Rey, EMA, Martin, AR, Arnal, CF, Gomez, MVM, Parreño, IA, Moreno, SG, González, JMR, Rull, FJC, Martin, DM, Deulofeu, AM, Martínez, SB, Errasti, AM, Pardo, GS, de Fez, PC. CBCT dose optimisation in prostate IGRT. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).

Bargalló, HV, Aguilar, NT, Sala, NJ, Fernández, JPA, Marco, CA, Franco, PG, Rey, EMA, Pagès, MB, Martínez, AR, Perea, AD, Molinero, VR, García, JR, Bernardó, NF, de Fez, PC. Dosimetric Impact of Different CT Image Sets on Lung SBRT Planning. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).

Gomis-Sellés, E, Maldonado, A, Gaztañaga, M, Vera, V, Ajulia, O, Sancho, G, Siva, S, Lopez-Campos, F, Couñago, F. Impact of PSMA-PET/CT on Radiotherapy Decisions: Is There a Clinical Benefit?. Cancers. 2025; 17(8)DOI:10.3390/cancers17081350. PMID:40282526. IF:4.400(Q2/3D).

Otero-Pla, E, Raspall, MJF, Franco, PG, Martínez, JF, Saladich, IG, Sala, NJ, Gisbert, ML, Cordero, JR, Verdum, JI, Sancho-Pardo, G. Mapping clinical and imaging factors that might predict cardiac events in breast cancer patients. Frontiers in Oncology. 2025; 15DOI:10.3389/fonc.2025.1552908. PMID:40134591. IF:3.300(Q2/4D).

Zamora, V, Bosch, G, Becerra, V, Garin, O, Avila, M, Gutiérrez, C, Suárez, JF, Goñi, A, Macías, V, Mariño, A, Hervás, A, Herruzo, I, Cabrera, P, de León, JP, Sancho, G, Pont, A, Rubio-Valera, M, Alonso, J, Cots, F, Guedea, F, Castells, M, Ferrer, M. Economic Evaluation of Traditional Treatments for Localized Prostate Cancer: A 10-Year Cohort Study. EUROPEAN JOURNAL OF CANCER CARE. 2025; 2025(1)DOI:10.1155/ecc/3563061. PMID:. IF:1.900(Q2/4D).

Acosta, PM, Malaver, G, Padin, TG, Gamboa, O, Singh, C, Rodriguez, C, Balart, J, Zubieta, C, Bouleftour, W, Magné, N, Penagos, P, Fino, D. MAGNETIC RESONANCE SPECTROSCOPY IN THE POST-TREATMENT METABOLIC CHARACTERIZATION OF BRAIN TUMORS OF GLIAL ORIGIN OF CENTRAL NERVOUS SYSTEM. NEURO-ONCOLOGY. 2024; 26DOI:10.1093/neuonc/noae165.0820. PMID:. IF:13.400(Q1/1D).

Mármol, MCC, Aguado, M, Cajal, TRY, Gallardo, A, Catasus, L, Gonzalez, A, Mendez, JE, Lasa, A, Arumi, M, Rubio, OG, Serra, JB, Hernandez, FM, von Deimling, A, Kommoss, FKF, Espinosa, I. Non-C19MC-altered embryonal tumor with multilayered rosettes in a young woman with DICER1 syndrome: case report and review of the literature. Pathologica. 2024; 116(3)DOI:10.32074/1591-951X-970. PMID:38979591. IF:(Q/D).

Basterretxea, L, Hernandez, A, Gurruchaga, I, Mediavilla, BG, Espinos, EL, Esteban, B, Cacho, D, Congregado, B, Belenchon, IR, Sancho, G, Lainez, N, Buchser, D, Sanguedolce, F, Lashey, M, Duran, I. PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).

Garcia-Valdecasas, B, Matias, I, Capdevila, E, Isern, J, Guix, J, Llurba, E. Evaluation of a new technique to fill the defect generated after conservative surgery for breast cancer. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

P rez-Montero, H, Godino, O, L pez, L, Lin, Y, Mera, MA, Navarro-Martin, A. Outcomes of postsurgical spine SBRT. A radical therapy for spinal cord compression. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Sosa-Fajardo, P, Mart n-Mart n, M, Luna-Tirado, J, Valtue a-Peydr , G, Alvarez-Gonz lez, AM, Barrientos, PM, Farr -Bernad , N, Gonz lez-del-Portillo, E, Gonz lez-Ruiz, MA, Linares, NA, Barrionuevo-Castillo, P, Blanco-Villar, M, Vera-Barrag n, V, Mateos-Dom nguez, M, Castro-G mez, JE, Pe a-Huertas, M, Zapatero-Ortu o, J, Diezhandino, P, Eito-Valdovinos, C, Guerrero-G mez, L, Bobo-Jaureguizar, A, V zquez-Barreiro, B, Rico-Oses, M, Cou ago, F. Stage III NSCLC Treatment Patterns in Spain. A Population-Based Study of the GOECP-SEOR.. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).

Tejedor, N, Jornet, N, Gallego, P, Sancho, G, Soto-Cambres, AM, Mera, A, P rez-Alija, J, Ans n, C, Vivancos, H, Ruiz, A, Barcel , M, Leo, F, Dom nguez, A, Riu, V, Carrasco, P. Validation of the dosimetric accuracy of MR-only treatment planning solution for prostate cancer. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).